CareFirst and Exagen Diagnostics Announce Evidence Development Agreement for AVISE® Lupus Diagnostic Test

August 20, 2018 Source: CareFirst BlueCross BlueShield Press Release CareFirst BlueCross BlueShield (CareFirst) and Exagen Diagnostics, Inc. (Exagen) today announced an agreement to collaborate to study the impact of Exagen’s proprietary AVISE Lupus test.  As part of the agreement, select CareFirst members will have access to the AVISE Lupus test to aid in the differential […] Read More